Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03916978 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Autologous PRP Intra Ovarian Infusion to Restore Ovarian Function in Menopausal Women

Study acronym: PRP
StatusRecruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jan 30, 2026 to Jan 30, 2027
    • Study completion date: Jul 30, 2026 to Jul 30, 2028
    v11
  2. Re-verified, no change to tracked fieldsv10
  3. Primary completion date: Jan 30, 2024 to Jan 30, 2026
    • Study completion date: Jan 30, 2024 to Jul 30, 2026
    v9
  4. Primary and study completion dates: Jan 30, 2023 to Jan 30, 2024v8
  5. Primary and study completion dates: Jan 30, 2021 to Jan 30, 2023v7 Show 7 more changesShow less
    • Primary endpoints revised (2)
    • Interventions: PRP (Biological), Placebo (Other) to Autologous PFP intra ovarian infusion (Biological), Autologous PRP intra ovarian infusion (Biological)
    • Eligibility criteria expanded, about 50 words
    • Secondary endpoints revised (5)
    • Study description shortened, about 25 words
    • Site contact updated
    • Study title expanded, about 4 words
Show 5 earlier versionsHide 5 earlier versions
  1. Primary completion date: Oct 2020 to Jan 30, 2021
    • Study completion date: Jan 2021 to Jan 30, 2021
    • Eligibility criteria expanded, about 22 words
    v6
  2. Site contact updatedv5
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jun 6, 2019 to May 21, 2019
    • Secondary endpoints revised (5)
    • Site details revised
    v4
  4. Start date: May 6, 2019 to Jun 6, 2019v3
  5. Start date: Apr 2019 to May 6, 2019
    • Site contact updated
    • Study description expanded, about 3 words
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Autologous PRP intra ovarian infusion may restore ovarian function, may promote folliculogenesis and may improve hormonal profile of women in menopause.
Trial Details
NCT Number NCT03916978
Lead Sponsor Genesis Athens Clinic
Collaborators: National and Kapodistrian University of Athens
Conditions
(from sponsor)		 Infertility, Female, Anovulatory Infertility, Menopause, Amenorrhea
Related terms Amenorrhea, Infertility, Female
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov